Global Pharma Regulatory Management Systems Market Report
- SKU: S/ID-32
- Type: Full Report
- November 16, 2021
- Format: Pdf
- Industry: Pharmaceuticals
- Saturday, March 15, 2025
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Description
Global Pharma Regulatory Management Systems Market Report, Growth, Trends, and Forecast
The global life science clinical trial system market is likely to generate USD 596.85 million by the end of 2027 by registering a CAGR of 12.54% during the forecast period, 2020-2027. It is attributed to rising industry-academia collaborations, the increasing number of clinical trials, increasing technology adoption, and government support for research trials. Additionally, rapid growth of healthcare IT, high R&D expenditure by life science and clinical research organizations, and adoption of CTMS solutions will propel the growth of global life science clinical trial system market.
Table Of Content
Table of Contents
Chapter 1. Research Strategic Development …………………………………………….. 17
1.1 Product Overview ……………………………………………….. 17
Chapter 2. Research Methodology ………………………………………………………….. 19
2.1 Secondary Research ……………………………………………. 19
2.2 Primary Research ……………………………………………….. 19
2.3 Data Triangulation ………………………………………………. 19
2.4 Historical & Forecast Data ……………………………………. 20
2.5 Identification of Segment …………………………………….. 20
2.6 Market Size Calculation ……………………………………….. 20
2.7 Research Objective ……………………………………………… 20
Chapter 3. Executive Summary ……………………………………………………………….. 22
3.1 Key Findings ……………………………………………………….. 22
Chapter 4. Global Pharma Regulatory Management Systems Market Insights 23
4.1 Economic Factor Analysis …………………………………….. 23
23
4.1.1 Global Pharma Regulatory Management Systems Market: Growth Drivers ………………………………. 23
4.1.1.1 Rising number of clinical trials ……………………… 23
4.1.1.2 Rising investment in digital infrastructure ……… 25
4.1.2 Global Pharma Regulatory Management Systems Market: Opportunities ………………………………… 26
4.1.2.1 Rising number of chronic diseases ………………… 26
4.1.3 Global Pharma Regulatory Management Systems Market: Challenges …………………………………….. 27
4.1.3.1 Budget Constraints ……………………………………… 27
4.1.4 Global Pharma Regulatory Management Systems Market: Trends …………………………………………… 27
4.1.4.1 Outsourcing of clinical trials in emerging countries …………………………………………………… 27
4.2 Technological Advancement ………………………………… 28
4.3 Competitor and Product Analysis ………………………….. 29
4.4 Regulatory Framework for Global Pharma Regulatory Management Systems Market ……………………………… 29
4.5 Porter’s Five forces analysis …………………………………. 30
4.6 New Investment Analysis …………………………………….. 31
4.7 Economic Impact Study on Global Pharma Regulatory Management Systems Market ……………………………… 32
4.8 Impact of COVID-19 on Global Pharma Regulatory Management Systems Market ……………………………… 33
Chapter 5. Global Life Science Clinical trial system (EDC) Market: Overview … 35
5.1 Global Life Science Clinical trial system (EDC) Market Size, By Value (USD Million) & Forecast (2016-2027) . 35
5.2 Global Life Science Clinical trial system (EDC) Market Size & Share Forecast (2016-2027) ……………………….. 35
5.2.1 Global Life Science Clinical trial system (EDC) Market Size (USD Million) & Share (%), By Component (2016-2027) ………………………………………………………………… 35
Table 3 Global Life Science Clinical trial system (EDC) Market Size (USD Million), By End User, 2016-2027 ………………….. 36
Table 4: Global Life Science Clinical trial system (EDC) Market Share, By End User, By Value, 2016-2027 ………………. 37
Table 5 : Global Life Science Clinical trial system (EDC) Market Size (USD Million), By Region 2016-2027 ……………….. 37
Table 6 : Global Life Science Clinical trial system (EDC) Market Share, By Region, By Value 2016-2027 ………………….. 38
Chapter 6. Global Pharma Regulatory Management Systems Market: Overview 39
6.1 Global Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ………………………………………………………………… 39
6.2 Global Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) ……………. 39
6.2.1 Global Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………………………….. 39
Table 8 Global Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 ………… 40
Table 9 : Global Pharma Regulatory Management Systems Market Size (USD Million), By Region 2016-2027 ……. 41
Chapter 7. North America Pharma Regulatory Management Systems Market: Overview 43
7.1 North America Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ……………………………………………………….. 43
7.2 North America Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) .. 43
7.2.1 North America Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………… 43
Table 11 North America Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 …………………………………………………………. 44
Table 12 : North America Pharma Regulatory Management Systems Market Size (USD Million), By Country 2016-2027………………………………………………………………….. 45
Chapter 8. Europe Pharma Regulatory Management Systems Market: Overview 47
8.1 Europe Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ………………………………………………………………… 47
8.2 Europe Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) ……………. 47
8.2.1 Europe Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………………………….. 47
Table 14 Europe Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 48
Table 15 : Europe Pharma Regulatory Management Systems Market Size (USD Million), By Country 2016-2027 ….. 49
Chapter 9. Asia Pacific Pharma Regulatory Management Systems Market: Overview 51
9.1 Asia Pacific Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ………………………………………………………………… 51
9.2 Asia Pacific Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) ……………. 51
9.2.1 Asia Pacific Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………………………….. 51
Table 17 Asia Pacific Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 52
Table 18 : Asia Pacific Pharma Regulatory Management Systems Market Size (USD Million), By Country 2016-2027 ….. 53
Table 19 : Asia Pacific Pharma Regulatory Management Systems Market Share, By Country, By Value 2016-2027 ……… 54
Chapter 10. South America Pharma Regulatory Management Systems Market: Overview 55
10.1 South America Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ……………………………………………………….. 55
10.2 South America Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) .. 55
10.2.1 South America Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………… 55
Table 21 South America Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 …………………………………………………………. 56
Table 22 : South America Pharma Regulatory Management Systems Market Size (USD Million), By Country 2016-2027………………………………………………………………….. 57
Chapter 11. Middle East & Africa Pharma Regulatory Management Systems Market: Overview ………………………………………………………………………………….. 59
11.1 Middle East & Africa Pharma Regulatory Management Systems Market Size, By Value (USD Million) & Forecast (2016-2027) ……………………………………………………….. 59
11.2 Middle East & Africa Pharma Regulatory Management Systems Market Size & Share Forecast (2016-2027) .. 60
11.2.1 Middle East & Africa Pharma Regulatory Management Systems Market Size (USD Million) & Share (%), By Component (2016-2027) ……………………………………… 60
Table 24 Middle East & Africa Pharma Regulatory Management Systems Market Size (USD Million), By Application, 2016-2027 …………………………………………………………. 61
Table 25 : Middle East & Africa Pharma Regulatory Management Systems Market Size (USD Million), By Country 2016-2027………………………………………………………………….. 62
Chapter 12. Company Profiles ………………………………………………………………….. 63
12.1 Instem plc ……………………………………………………………………….. 63
12.1.1 Business Overview ……………………………………… 63
12.1.2 Financial Overview (USD Million) ………………….. 63
12.1.3 Revenue by Segmentation, 2019 …………………. 64
12.1.4 Revenue by Region, 2019…………………………….. 64
12.1.5 Key Solutions and Services …………………………… 64
12.1.6 Key Personnel …………………………………………….. 64
12.1.7 Key Contact Person …………………………………….. 65
12.1.8 SWOT Analysis ……………………………………………. 65
12.2 NNIT A/S ………………………………………………………………………….. 66
12.2.1 Business Overview ……………………………………… 66
12.2.2 Financial Overview (USD Million) ………………….. 66
12.2.3 Revenue by Segmentation, 2019 ………………….. 67
12.2.4 Key Solution and Services ……………………………. 67
12.2.5 Key Personnel …………………………………………….. 67
12.2.6 Key Contact Person …………………………………….. 67
12.2.7 SWOT Analysis ……………………………………………. 68
12.3 EXTEDO GmbH …………………………………………………………………. 69
12.3.1 Business Overview ……………………………………… 69
12.3.2 Key Products and Solutions ………………………….. 69
12.3.3 Key Development ……………………………………….. 69
12.3.4 Key Personnel …………………………………………….. 70
12.3.5 Key Contact Person …………………………………….. 70
12.3.6 SWOT Analysis ……………………………………………. 71
12.4 Amplexor …………………………………………………………………………. 72
12.4.1 Business Overview ……………………………………… 72
12.4.2 Key Products and Solutions ………………………….. 72
12.4.3 Key Developments ……………………………………… 73
12.4.4 Key Personnel …………………………………………….. 73
12.4.5 Key Contact Person …………………………………….. 73
12.4.6 SWOT Analysis ……………………………………………. 73
12.5 MasterControl Inc. ……………………………………………………………. 74
12.5.1 Business Overview ……………………………………… 74
12.5.2 Key Products and Solutions ………………………….. 74
12.5.3 Key Personnel …………………………………………….. 74
12.5.4 Key Contact Person …………………………………….. 74
12.5.5 SWOT Analysis ……………………………………………. 75
12.6 IQVIA Holdings Inc. …………………………………………………………… 76
12.6.1 Business Overview ……………………………………… 76
12.6.2 Financial Overview (USD Million) ………………….. 76
12.6.3 Revenue by Segmentation, 2020 ………………….. 77
12.6.4 Revenue by Region, 2020…………………………….. 77
12.6.5 Key Products and Solution …………………………… 77
12.6.6 Key Personnel …………………………………………….. 77
12.6.7 Key Contact Person …………………………………….. 77
12.6.8 SWOT Analysis ……………………………………………. 78
12.7 ICON plc ………………………………………………………………………….. 79
12.7.1 Business Overview ……………………………………… 79
12.7.2 Financial Overview (USD Million) ………………….. 79
12.7.3 Revenue by Region, 2020…………………………….. 80
12.7.4 Key Solution and Services ……………………………. 80
12.7.5 Key Personnel …………………………………………….. 80
12.7.6 Key Contact Person …………………………………….. 80
12.7.7 SWOT Analysis ……………………………………………. 81
12.8 uMed ………………………………………………………………………………. 82
12.8.1 Business Overview ……………………………………… 82
12.8.2 Key Solution and Services ……………………………. 82
12.8.3 Key Personnel …………………………………………….. 82
12.8.4 SWOT Analysis ……………………………………………. 83
12.9 ArisGlobal LLC ………………………………………………………………….. 84
12.9.1 Business Overview ……………………………………… 84
12.9.2 Key Products and Solutions ………………………….. 84
12.9.3 Key Personnel …………………………………………….. 84
12.9.4 Key Contact Person …………………………………….. 84
12.9.5 SWOT Analysis ……………………………………………. 85
Contact Us
